
Khon Kaen
Articles
-
Jan 19, 2025 |
bmcpublichealth.biomedcentral.com | Khon Kaen
ReferencesCOVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513–36. Article Google Scholar Beaney T, Clarke JM, Jain V, Golestaneh AK, Lyons G, Salman D, et al. Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? J R Soc Med. 2020;113(9):329–34.
-
Jan 7, 2025 |
cardiab.biomedcentral.com | Khon Kaen
This is a retrospective study based on the clinical data of patients with CHF from MIMIC-IV version 2.2, which includes information on over 65,000 ICU admissions and more than 200,000 emergency department admissions at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, between 2008 and 2019 [33]. The Institutional Review Board of BIDMC waived the requirement for informed consent and approved the sharing of research resources.
-
Dec 2, 2024 |
ccforum.biomedcentral.com | Khon Kaen
ReferencesDe Souza D, Machado F. Epidemiology of pediatric septic shock. J Pediatr Intensive Care. 2019;08(01):003–10. Article Google Scholar Watson RS, Carrol ED, Carter MJ, Kissoon N, Ranjit S, Schlapbach LJ. The burden and contemporary epidemiology of sepsis in children. Lancet Child Adolesc Health. 2024;8(9):670–81. Article PubMed Google Scholar Samransamruajkit R, Wong JJM, Smathakane C, Anantasit N, Sunkonkit K, Ong J, et al.
-
Nov 12, 2024 |
bmcpublichealth.biomedcentral.com | Chiang Mai |Khon Kaen
Age-standardized prevalence of hypertension has remained relatively unchanged in Thai adults from 2004 to 2019–2020 and remains higher than the global average [9]. Meanwhile, the proportion of Thai adults with controlled BP increased favorably from 2004 until 2014, but decreased by 7% points between 2014 and 2019–2020. Awareness of hypertension increased by 25% between 2004 and 2014, with the biggest increase occurring between 2004 and 2009. It then dropped by 5% from 2014 to 2019–2020.
-
Oct 30, 2024 |
link.springer.com | Khon Kaen
AbstractThe Cholangiocarcinoma Screening and Care Program (CASCAP) has been launched since 2013 to detect early-stage cholangiocarcinoma and reduce the disease death. However, the clinical utility of the CASCAP remains unclear. To compare survival outcomes between two time periods: before and after 2013, when significant changes in treatment strategies were implemented, and to evaluate the efficacy of the ultrasound-based screening program, in an Asian region endemic for cholangiocarcinoma.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →